Effects of Dapagliflozin on myocardial performance in non-diabetic patients with Heart failure with reduced and mid-range ejection fraction (DAPA ECHO trial)

31 August 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Phenotypic approach in heart failure therapy Pharmacotherapy ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by